ME Therapeutics

Business Services · Canada · 1-10 Employees

View Company Info for Free

Overview

Headquarters

177 Robson St, Vancouver, British Columb...

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About ME Therapeutics

ME Therapeutics Inc. is a preclinical stage biotechnology company focused on developing next-generation therapeutics that target immune suppression in cancer. The company specializes in creating novel drugs aimed at myeloid cells to directly treat cancer and enhance the efficacy of existing immuno-oncology treatments. With a strong background in immunology related to cancer and inflammation, ME Therapeutics aims to address previously untreatable cancers through innovative approaches. Their work in immuno-oncology represents a significant advancement in cancer treatment, leveraging the immune system to combat various cancer types.Explore more
ME Therapeutics's Social MediaPopular SearchesME TherapeuticsME Therapeutics IncSIC Code 87,873NAICS Code 54,541Show more

ME Therapeutics Org Chart

PhoneEmail
QM
Canada flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JP
Canada flag for contact location.

Director, Chair of The Audit Committee

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is ME Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to ME Therapeutics

Compare insights from companies similar to ME Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

ME Therapeutics

<$5M
1-10
Private
-
-
QM
Quinn MartinChief Financial Officer
$15.5M
11-50
Private
-
2004
SH
Sonida HorngGeneral Manager
$6.7M
11-50
Private
-
2011
JP
Julie PetianeDE Contedo Web Editor
<$5M
1-10
Private
-
2013
Elaine Allison, Co-Founder & Chief Executive Officer at Novelogics Biotechnology
Elaine AllisonCo-Founder & CEO
<$5M
11-50
Private
$12.5M
2017
JM
Jim McGuireDirector of Pharmacology
<$5M
1-10
Private
$85M
2018
DL
Dylan LeeResearch, Cell Engineering Associate I
<$5M
1-10
Private
-
2018
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

ME Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

ME Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ME Therapeutics.

ME Therapeutics Tech Stack

A closer look at the technologies used by ME Therapeutics

ME Therapeutics News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding ME Therapeutics

What is ME Therapeutics's official website?
ME Therapeutics's official website is www.metherapeutics.com
What is ME Therapeutics's Revenue?
ME Therapeutics's revenue is <$5 Million
What is ME Therapeutics's SIC code?
ME Therapeutics's SIC: 87,873
What is ME Therapeutics's NAICS code?
ME Therapeutics's NAICS: 54,541
How many employees does ME Therapeutics have?
ME Therapeutics has 1-10 employees
What industry does ME Therapeutics belong to?
ME Therapeutics is in the industry of: Business Services, Research & Development
What is ME Therapeutics competition?
ME Therapeutics top competitors include: Notch Therapeutics, Novelogics Biotechnology, Forbius, Orion Biotechnology
What technology does ME Therapeutics use?
Some of the popular technologies that ME Therapeutics uses are: WordPress.org, PHP, Google Workspace, Gmail
Who is the CFO of ME Therapeutics?
ME Therapeutics's CFO is Quinn Martin
What does ME Therapeutics do?

ME Therapeutics Inc. is a preclinical stage biotechnology company focused on developing next-generation therapeutics that target immune suppression in cancer. The company specializes in creating novel drugs aimed at myeloid cells to directly treat cancer and enhance the efficacy of existing immuno-oncology treatments. With a strong background in im... munology related to cancer and inflammation, ME Therapeutics aims to address previously untreatable cancers through innovative approaches. Their work in immuno-oncology represents a significant advancement in cancer treatment, leveraging the immune system to combat various cancer types.Read More

What are ME Therapeutics social media links?
ME Therapeutics Twitter page
Is ME Therapeutics a public company?
ME Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about ME Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.